Personal stories

J&J provides annual scholarships to the program to elevate, empower, and advocate for the nursing profession.

Learn more about Robert Zhao, Ph.D, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.

October 2024 Newsletter: Supporting the early-stage healthcare innovation ecosystem

J&J Impact Ventures, an investment fund within the J&J Foundation, has joined Villgro Africa to address the gender disparity in funding and support for women-led healthcare start-ups in Africa by launching a business incubation program to support.

This year’s award went to six teams who participated in the Global Health Challenge which asked: How can we use technology to make good health and access to quality care more accessible for all?

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 400,000 patients recover from heart injuries.

Johnson & Johnson is restoring the true meaning of healthcare by developing advanced treatments and smarter and less invasive solutions for today’s most complex diseases.